Does GILTERITINIB Cause Lung infiltration? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Lung infiltration have been filed in association with GILTERITINIB (Xospata). This represents 0.5% of all adverse event reports for GILTERITINIB.
19
Reports of Lung infiltration with GILTERITINIB
0.5%
of all GILTERITINIB reports
13
Deaths
9
Hospitalizations
How Dangerous Is Lung infiltration From GILTERITINIB?
Of the 19 reports, 13 (68.4%) resulted in death, 9 (47.4%) required hospitalization, and 8 (42.1%) were considered life-threatening.
Is Lung infiltration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Lung infiltration?
PREDNISONE (243)
RITUXIMAB (240)
CYCLOPHOSPHAMIDE (228)
METHOTREXATE (216)
ADALIMUMAB (172)
DOXORUBICIN (164)
VINCRISTINE (160)
PREDNISOLONE (151)
EVEROLIMUS (136)
CYTARABINE (124)
Which GILTERITINIB Alternatives Have Lower Lung infiltration Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB